As on March 15, 2023, BioXcel Therapeutics Inc. (NASDAQ: BTAI) started slowly as it slid -3.59% to $19.60. During the day, the stock rose to $20.33 and sunk to $19.42 before settling in for the price of $20.33 at the close. Taking a more long-term approach, BTAI posted a 52-week range of $8.80-$34.12.
Top 5 EV Tech Stocks to Buy for 2023
According a new report published by BloombergNEF on investment in the energy transition, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now.
Click Here to Download the FREE Report.
Nevertheless, stock’s Earnings Per Share (EPS) this year is -7.00%. This publicly-traded company’s shares outstanding now amounts to $28.02 million, simultaneously with a float of $18.99 million. The organization now has a market capitalization sitting at $653.07 million. At the time of writing, stock’s 50-day Moving Average stood at $28.65, while the 200-day Moving Average is $17.85.
It is quite necessary to find out the efficiency of the corporate organization, which has 89 number of employees on its payroll. For the Profitability, stocks gross margin was +94.67, operating margin was -42572.00 and Pretax Margin of -44201.87.
BioXcel Therapeutics Inc. (BTAI) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Biotechnology industry. BioXcel Therapeutics Inc.’s current insider ownership accounts for 32.22%, in contrast to 47.90% institutional ownership. According to the most recent insider trade that took place on Jan 20, this organization’s Chief Scientific Officer sold 50,000 shares at the rate of 30.00, making the entire transaction reach 1,500,000 in total value, affecting insider ownership by 8,397. Preceding that transaction, on Jan 20, Company’s Chief Medical Officer sold 29,713 for 30.00, making the whole transaction’s value amount to 891,390. This particular insider is now the holder of 0 in total.
BioXcel Therapeutics Inc. (BTAI) Earnings and Revenue Records
If we go through the results of last quarter, which was made public on 9/29/2022, the company posted -$1.49 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at -$1.35) by -$0.14. This company achieved a net margin of -44201.87 while generating a return on equity of -111.08. Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.62 per share during the current fiscal year.
BioXcel Therapeutics Inc.’s EPS decrease for this current 12-month fiscal period is -7.00% and is forecasted to reach -4.28 in the upcoming year.
BioXcel Therapeutics Inc. (NASDAQ: BTAI) Trading Performance Indicators
Let’s observe the current performance indicators for BioXcel Therapeutics Inc. (BTAI). It’s Quick Ratio in the last reported quarter now stands at 10.30. The Stock has managed to achieve an average true range (ATR) of 2.08. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 1632.68.
In the same vein, BTAI’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -5.92, a figure that is expected to reach -1.72 in the next quarter, and analysts are predicting that it will be -4.28 at the market close of one year from today.
Technical Analysis of BioXcel Therapeutics Inc. (BTAI)
Through scrutinizing the latest numbers posted by the [BioXcel Therapeutics Inc., BTAI], it can be observed that its last 5-days Average volume of 0.89 million was better the volume of 0.43 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 5.12% While, its Average True Range was 2.16.
Raw Stochastic average of BioXcel Therapeutics Inc. (BTAI) in the period of the previous 100 days is set at 38.78%, which indicates a major rise in contrast to 1.34% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 96.24% that was higher than 82.20% volatility it exhibited in the past 100-days period.